secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ingevity Corp (NGVT)
CIK:        0001653477
Form:       8-K
Filed at:   2024-10-29T23:59:59+00:00
Accession:  0001653477-24-000096
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ingevity Q3 net loss $107.2M; sales down 16% YoY; affirms FY adjusted EBITDA guidance
--------------------------------------------------------------------------------

- Net sales $376.9M, down 16% YoY, primarily due to Performance Chemicals repositioning.
- Net loss $107.2M ($2.95 diluted EPS) includes $86.9M restructuring charges and $100M contract termination fees.
- Adjusted EPS $1.10; adjusted EBITDA $106.4M (28.2% margin).
- Full-year guidance: sales $1.40-$1.50B, adjusted EBITDA $350-$360M.
- Operating cash flow $46.5M, free cash flow $28.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1653477/000165347724000096/0001653477-24-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1653477/000165347724000096/ngvt-20241029.htm
  HTML page:      https://secwatch.observer/filing/0001653477-24-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer